Table 2.
Baseline characteristics of grass-allergic patients.
| Clinical and demographic characteristics | All patients n = 209 (%) | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 86 (41.1) | |||
| Female | 123 (58.9) | |||
| Skin tests | ||||
| Grass positive | 187 (93.0) | |||
| Olive positive | 111 (55.2) | |||
| Profilin positive | 49 (24.9) | |||
| Polcalcin positive | 27 (14.2) | |||
| Allergy symptoms | ||||
| Rhinoconjunctivitis | ||||
| No | 6 (2.9) | |||
| Mild | 106 (50.7) | |||
| Moderate-severe | 97 (46.4) | |||
| Asthma | ||||
| No | 46 (22.0) | |||
| Mild | 118 (56.5) | |||
| Moderate-severe | 45 (21.5) | |||
| Immunotherapy | ||||
| No | 124 (59.3) | |||
| Grass immunotherapy | 85 (40.7) | |||
| Mean | Median | SD* | IQR† | |
| Age | 28.7 | 28 | 12.0 | 19–37.5 |
| Total IgE (kU/L) | 252.3 | 142.5 | 295.1 | 59.0–301.5 |
| Lolium sIgE‡(kUA/L) | 39.4 | 19.0 | 56.9 | 7.8–47.8 |
| rPhl p 1,5 sIgE (kUA/L) | 34.3 | 15.1 | 48.8 | 5.4–42.3 |
SD*, standard deviation; IQR†, interquartile range; sIgE‡, specific Immunoglobulin E.